Skip to main content
Signal8
Stimart Tryn profile photo

Tryn Stimart

CIK: 0001834424

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AbCellera Biologics Inc. logo
ABCL

AbCellera Biologics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • AbCellera Biologics Inc. logo
    ABCL

    AbCellera Biologics Inc.

    Jan 1, 2026
    Award(A)

    Share option (right to buy)

    Direct
    539.3K shares-
  • AbCellera Biologics Inc. logo
    ABCL

    AbCellera Biologics Inc.

    Jan 1, 2025
    Award(A)

    Share option (right to buy)

    Direct
    832K shares-

1-2 of 2

About Stimart Tryn

Stimart Tryn (SEC CIK 0001834424) files insider reports with the SEC as Chief Legal Officer of AbCellera Biologics Inc. (ABCL).

Signal8 holds 2 ownership filings by Stimart Tryn, all Form 4s, filed between Jan 3, 2025 and Jan 5, 2026. Those filings report 2 transactions, from Jan 1, 2025 to Jan 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Stimart Tryn's filings is in VANCOUVER, A1.

Recent filings by Stimart Tryn

  • Jan 1, 2026: Grant or award of ABCL derivative securities (Form 4, code A).
  • Jan 1, 2025: Grant or award of ABCL derivative securities (Form 4, code A).

Other insiders filing for AbCellera Biologics Inc. (ABCL)

How to read Form 4 transaction codes